Literature DB >> 2756912

Effect of obesity on bioelectrical impedance.

D S Gray1, G A Bray, N Gemayel, K Kaplan.   

Abstract

The purpose of this study was to validate the use of bioelectrical impedance in assessing human body composition and to explore the use of this technique in obesity. Eighty-seven adults varying widely in body composition (range: 8.8-59.0% body fat) underwent measurement of bioelectrical impedance and underwater weighing (density). Fat-free mass determined from density (FFMd) was compared with FFM estimated from bioelectric impedance according to previously published regression equations. Correlation coefficients were high at all levels of body fat (0.94-0.99) but impedance equations overestimated FFM compared with FFMd in subjects greater than 42% body fat. This effect was greatest in subjects greater than 48% body fat and a regression equation was derived for determination of FFM for these subjects. These data confirm the excellent agreement between body composition determined from bioelectrical impedance and density but suggest that caution should be used in applying existing regression equations to very obese subjects.

Entities:  

Mesh:

Year:  1989        PMID: 2756912     DOI: 10.1093/ajcn/50.2.255

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  41 in total

1.  Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.

Authors:  H Vestergaard; S Lund; C Bjørbaek; O Pedersen
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Myocardial insulin resistance in patients with syndrome X.

Authors:  H E Botker; N Moller; O Schmitz; J P Bagger; T T Nielsen
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Gender-related changes in body composition, muscle strength and power output after a short-term multidisciplinary weight loss intervention in morbid obesity.

Authors:  A Sartorio; N A Maffiuletti; F Agosti; C L Lafortuna
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

4.  Effect of Nasal Continuous Positive Airway Pressure Therapy on the Functional Respiratory Parameters and Cardiopulmonary Exercise Test in Obstructive Sleep Apnea Syndrome.

Authors:  Özge Oral Tapan; Can Sevinç; Bahriye Oya İtil; İbrahim Öztura; Berkant Muammer Kayatekin; Yücel Demiral
Journal:  Turk Thorac J       Date:  2015-12-14

5.  Changes in Body Adiposity, Dietary Intake, Physical Activity and Quality of Life of Obese Individuals Submitted to Intragastric Balloon Therapy for 6 Months.

Authors:  Marcella Rodrigues Guedes; Ricardo José Fittipaldi-Fernandez; Cristina Fajardo Diestel; Márcia Regina Simas Torres Klein
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

6.  22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts.

Authors: 
Journal:  Obes Facts       Date:  2015-04-30       Impact factor: 3.942

7.  Differences in quadriceps muscle strength and fatigue between lean and obese subjects.

Authors:  Nicola A Maffiuletti; Marc Jubeau; Urs Munzinger; Mario Bizzini; Fiorenza Agosti; Alessandra De Col; Claudio L Lafortuna; Alessandro Sartorio
Journal:  Eur J Appl Physiol       Date:  2007-05-03       Impact factor: 3.078

8.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 9.  What is the best size descriptor to use for pharmacokinetic studies in the obese?

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

10.  Quadriceps muscle function characteristics in severely obese and nonobese adolescents.

Authors:  Nicola A Maffiuletti; Marc Jubeau; Fiorenza Agosti; Alessandra De Col; Alessandro Sartorio
Journal:  Eur J Appl Physiol       Date:  2008-07       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.